The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[6-Amino-2-(N'-thiophen-2-ylmethylene-hydrazino)-purin-9-yl]-5-hydroxymethyl-tetrahydro-furan-3,4-diol ID: ALA608176
Max Phase: Preclinical
Molecular Formula: C15H17N7O4S
Molecular Weight: 391.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc(N/N=C/c2cccs2)nc2c1ncn2C1O[C@H](CO)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C15H17N7O4S/c16-12-9-13(20-15(19-12)21-18-4-7-2-1-3-27-7)22(6-17-9)14-11(25)10(24)8(5-23)26-14/h1-4,6,8,10-11,14,23-25H,5H2,(H3,16,19,20,21)/b18-4+/t8-,10-,11-,14?/m1/s1
Standard InChI Key: CEBYJLIWMBILKB-OXISBLNKSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
8.2792 -6.1375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5250 -5.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2625 -7.9875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5167 -5.1042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8292 -6.3000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2667 -4.8542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0167 -8.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7417 -5.4917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1417 -5.1042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6250 -7.5250 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8292 -4.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1417 -5.9042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2250 -8.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9792 -7.9875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3667 -5.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7667 -5.8917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2917 -5.0292 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.0792 -6.2792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4542 -6.2917 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.4917 -4.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6167 -6.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0667 -5.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5042 -9.4167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8250 -3.9125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.7292 -9.4167 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9792 -7.1917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1875 -7.1875 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 2 1 0
5 2 2 0
6 8 2 0
7 3 1 0
8 1 1 0
9 12 2 0
10 3 1 0
11 4 2 0
12 5 1 0
13 7 1 0
14 10 1 0
15 18 1 0
16 19 1 0
17 15 1 0
18 16 2 0
19 12 1 0
20 17 1 0
21 15 2 0
22 21 1 0
7 23 1 6
24 11 1 0
13 25 1 6
14 26 1 1
27 26 1 0
6 4 1 0
14 13 1 0
11 9 1 0
20 22 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 391.41Molecular Weight (Monoisotopic): 391.1063AlogP: -0.47#Rotatable Bonds: 5Polar Surface Area: 163.93Molecular Species: NEUTRALHBA: 12HBD: 5#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 6#RO5 Violations (Lipinski): 2CX Acidic pKa: 10.52CX Basic pKa: 4.57CX LogP: 0.33CX LogD: 0.30Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.29Np Likeness Score: -0.38
References 1. Niiya K, Thompson RD, Silvia SK, Olsson RA.. (1992) 2-(N'-aralkylidenehydrazino)adenosines: potent and selective coronary vasodilators., 35 (24): [PMID:1469688 ] [10.1021/jm00102a008 ]